Extends the sunset provision of the four (4) year pilot program to prevent drug overdoses through the establishment of harm reduction centers for two (2) years to March 1, 2028.
Summary
H5171 extends Rhode Island’s existing harm reduction center pilot program for two additional years, moving the sunset date from March 1, 2026 to March 1, 2028. The bill keeps in place the framework authorizing community-based harm reduction centers designed to prevent overdoses by allowing people to safely consume pre-obtained substances, including smoking pre-obtained substances, in a supervised setting. These centers must provide healthcare professionals on site and offer referrals for counseling or other medical treatment as appropriate.
The bill also preserves the requirement that any proposed harm reduction center receive express municipal authorization before opening. A city or town council, or equivalent governing body, must approve the center’s operation, exact location, and hours. The Department of Health is directed to promulgate regulations for the program, and the Department of Health and the Attorney General must submit continuation recommendations by January 31, 2028. Unless further extended by the General Assembly, the program will then expire on March 1, 2028.
Impact
The bill amends Chapter 23-12.10 of the General Laws by extending the sunset date for the harm reduction center pilot program and related advisory framework. It does not create a new statewide mandate for centers; instead, it prolongs the existing pilot structure under which centers may operate only with municipal approval and under regulations issued by the Department of Health. The extension affects municipalities considering such centers, public health agencies, healthcare providers involved in overdose prevention, and people who use drugs and may seek supervised consumption and referral services.
Sentiment
The available voting history suggests the bill had majority support, but not unanimous backing. The House approved an amendment overwhelmingly and then passed the bill as amended by a solid margin, indicating broad acceptance of the extension while still reflecting some opposition. No committee transcript is available, so the recorded votes are the main indicator of sentiment. Overall, the bill appears to have been viewed as a public health measure aimed at continuing an existing overdose-prevention pilot.
Contention
The main point of contention is the concept of harm reduction centers themselves, especially the authorization of supervised consumption and smoking of pre-obtained substances. Supporters appear to favor extending a program intended to reduce overdose deaths and connect participants with healthcare and counseling, while opponents likely object to the policy on public safety, drug use, or local control grounds. The bill’s municipal authorization requirement also reflects a compromise point, preserving local veto power over whether a center may open, where it may be located, and when it may operate.